Cheng Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cheng Cheng has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Bingfang He
School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China
5 shared publicationsYongqin Su
2011 College, Nanjing Tech University, Nanjing, China
4 shared publicationsBixia Zhou
College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China
3 shared publicationsYufan Huang
College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China
3 shared publications- Bingfang He
School of Pharmaceutical Sciences, Nanjing Tech University, 30 Puzhunan Road, Nanjing 211816, China
2 shared publications Bingrui An
School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China
2 shared publications
Latest Publications
- 8 October 2026
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 16 (21) , 21717-21728
Blocking, Widening, Regulating, and Tailoring-Based Engineering of an Imine Reductase for Asymmetric Reductive Amination of Sterically Demanding Ketones with Ammonia
Chiral amines are essential building blocks for the synthesis of pharmaceuticals. Although imine reductases (IREDs) have emerged as powerful biocatalysts for chiral amine synthesis, their application in reductive amination using ammonia as an amino donor remains limited, especially for sterically demanding ketone substrates. Herein, we developed a BWRT (Blocking, Widening, Regulating, and Tailoring) strategy for engineering the active-site pocket of an IRED from Saccharopolyspora erythraea (SeIRED). The engineered variant, SeIRED-M4, containing 17 amino acid mutations, exhibited a 23,300-fold increase in specific activity along with a 19 °C increase in melting temperature (Tm) relative to the wild-type enzyme. SeIRED-M4 efficiently catalyzed the asymmetric reductive amination of a broad range of ketones with ammonia, affording the corresponding chiral amines with up to 98% conversion and >99% ee. The synthetic applicability of SeIRED-M4 was further demonstrated through the gram-scale synthesis of sitagliptin ((R)-1b), achieving 93% conversion and >99% ee at a substrate loading of up to 40 g/L. Collectively, this study demonstrates an active-site engineering strategy that improves catalytic performance by regulating substrate accessibility and productive binding orientation, highlighting the importance of controlling substrate-binding conformations in biocatalyst development for pharmaceutical applications.
- 8 October 2026
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 16 (21) , 21717-21728
Blocking, Widening, Regulating, and Tailoring-Based Engineering of an Imine Reductase for Asymmetric Reductive Amination of Sterically Demanding Ketones with Ammonia
Chiral amines are essential building blocks for the synthesis of pharmaceuticals. Although imine reductases (IREDs) have emerged as powerful biocatalysts for chiral amine synthesis, their application in reductive amination using ammonia as an amino donor remains limited, especially for sterically demanding ketone substrates. Herein, we developed a BWRT (Blocking, Widening, Regulating, and Tailoring) strategy for engineering the active-site pocket of an IRED from Saccharopolyspora erythraea (SeIRED). The engineered variant, SeIRED-M4, containing 17 amino acid mutations, exhibited a 23,300-fold increase in specific activity along with a 19 °C increase in melting temperature (Tm) relative to the wild-type enzyme. SeIRED-M4 efficiently catalyzed the asymmetric reductive amination of a broad range of ketones with ammonia, affording the corresponding chiral amines with up to 98% conversion and >99% ee. The synthetic applicability of SeIRED-M4 was further demonstrated through the gram-scale synthesis of sitagliptin ((R)-1b), achieving 93% conversion and >99% ee at a substrate loading of up to 40 g/L. Collectively, this study demonstrates an active-site engineering strategy that improves catalytic performance by regulating substrate accessibility and productive binding orientation, highlighting the importance of controlling substrate-binding conformations in biocatalyst development for pharmaceutical applications.
- 18 September 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (38) , 29832-29856
Recent Advances in the Production and Biosynthesis of Oleanane-Type Pentacyclic Triterpenoids
Oleanane-type pentacyclic triterpenoids are a class of naturally occurring specialized metabolites with diverse biological activities. Conventional plant extraction and chemical synthesis are constrained by low yields, high costs, and a reliance on natural resources. With the development of synthetic biology and metabolic engineering, the biosynthetic pathways of these compounds can now be systematically reconstructed and optimized, providing new opportunities for efficient production. This review summarizes the classification of oleanane-type pentacyclic triterpenoids and outlines their biosynthetic pathways and recent progress in production platforms such as plant in vitro culture and microbial cell factories. In addition, we discuss major engineering strategies used to improve triterpenoid production, including increasing precursor supply, reducing competing pathways, implementing enzyme engineering and engineering cofactors, improving protein performance, subcellular compartmentalization, enhancing transport, and optimizing fermentation conditions. In view of the current progress, this review also identifies persistent challenges in the biosynthesis of these compounds and outlines potential strategies to address them.
- 18 September 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (38) , 29832-29856
Recent Advances in the Production and Biosynthesis of Oleanane-Type Pentacyclic Triterpenoids
Oleanane-type pentacyclic triterpenoids are a class of naturally occurring specialized metabolites with diverse biological activities. Conventional plant extraction and chemical synthesis are constrained by low yields, high costs, and a reliance on natural resources. With the development of synthetic biology and metabolic engineering, the biosynthetic pathways of these compounds can now be systematically reconstructed and optimized, providing new opportunities for efficient production. This review summarizes the classification of oleanane-type pentacyclic triterpenoids and outlines their biosynthetic pathways and recent progress in production platforms such as plant in vitro culture and microbial cell factories. In addition, we discuss major engineering strategies used to improve triterpenoid production, including increasing precursor supply, reducing competing pathways, implementing enzyme engineering and engineering cofactors, improving protein performance, subcellular compartmentalization, enhancing transport, and optimizing fermentation conditions. In view of the current progress, this review also identifies persistent challenges in the biosynthesis of these compounds and outlines potential strategies to address them.
- Open Access
- 28 April 2026
- Published by Elsevier in Military Medical Research
- Vol. 13 (1)
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
- 28 April 2026
- Published by Elsevier in Military Medical Research
- Vol. 13 (1)
Open AccessOctopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
- Open Access
Enhancing the Catalytic Activity of Candida antarctica Lipase B (CALB) for the Synthesis of Moxifloxacin Intermediates by Loop Engineering
This study addressed the issue of insufficient activity in CALB lipase during the catalytic synthesis of key chiral intermediates for moxifloxacin. A structure-guided protein engineering strategy was employed to systematically modify its functional domains. Through molecular dynamics simulations of CALB-I189K, multiple regions exhibiting high conformational flexibility were preliminarily identified. Subsequently, by integrating 3D structural alignment with active site pocket distance analysis, the functionally most critical region (143–146) was selected. A site-directed saturation mutation library was constructed specifically targeting this region. Building upon the previously reported CALB-I189K, a mutant I189K/L144R/A146K was ultimately obtained through high-throughput screening combined with chiral HPLC validation. This mutant maintains excellent stereoselectivity (E = 206.52) while enhancing catalytic efficiency (kcat/Κm) to 273.73 min−1·mM−1, approximately 4.5-fold that of I189K. At a substrate concentration of 1 M, it achieves 50% conversion within 2.6 h, demonstrating kinetic resolution capabilities approaching industrial standards. Molecular simulation analysis indicates that the L144R and A146K mutations synergistically enhance catalytic performance primarily by optimizing spatial distances between catalytic residues. This study not only provides a high-performance catalyst for the efficient biosynthesis of moxifloxacin chiral intermediates but also offers new insights for enzyme rational design based on dynamic structural information.
Open AccessEnhancing the Catalytic Activity of Candida antarctica Lipase B (CALB) for the Synthesis of Moxifloxacin Intermediates by Loop Engineering
This study addressed the issue of insufficient activity in CALB lipase during the catalytic synthesis of key chiral intermediates for moxifloxacin. A structure-guided protein engineering strategy was employed to systematically modify its functional domains. Through molecular dynamics simulations of CALB-I189K, multiple regions exhibiting high conformational flexibility were preliminarily identified. Subsequently, by integrating 3D structural alignment with active site pocket distance analysis, the functionally most critical region (143–146) was selected. A site-directed saturation mutation library was constructed specifically targeting this region. Building upon the previously reported CALB-I189K, a mutant I189K/L144R/A146K was ultimately obtained through high-throughput screening combined with chiral HPLC validation. This mutant maintains excellent stereoselectivity (E = 206.52) while enhancing catalytic efficiency (kcat/Κm) to 273.73 min−1·mM−1, approximately 4.5-fold that of I189K. At a substrate concentration of 1 M, it achieves 50% conversion within 2.6 h, demonstrating kinetic resolution capabilities approaching industrial standards. Molecular simulation analysis indicates that the L144R and A146K mutations synergistically enhance catalytic performance primarily by optimizing spatial distances between catalytic residues. This study not only provides a high-performance catalyst for the efficient biosynthesis of moxifloxacin chiral intermediates but also offers new insights for enzyme rational design based on dynamic structural information.
- 6 April 2026
- Published by Elsevier in Bioorganic Chemistry
- Vol. 175, 109842
Discovery, engineering and application of a maleate isomerase for efficient L-malic acid biosynthesis via dual-enzyme cascade with fumarase
- 6 April 2026
- Published by Elsevier in Bioorganic Chemistry
- Vol. 175, 109842
Discovery, engineering and application of a maleate isomerase for efficient L-malic acid biosynthesis via dual-enzyme cascade with fumarase
- Open Access
- 6 January 2026
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 110 (1) , 3
Cosolvent-induced spontaneous refolding of lipase
The overexpression of proteins in Escherichia coli often results in the formation of inclusion bodies, which are biologically inactive, especially for prot
- 6 January 2026
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 110 (1) , 3
Open AccessCosolvent-induced spontaneous refolding of lipase
The overexpression of proteins in Escherichia coli often results in the formation of inclusion bodies, which are biologically inactive, especially for prot
- Open Access
- 1 July 2025
- Published by Springer Nature in BMC Biotechnology
- Vol. 25 (1) , 1-10
An engineered self-cleavage fusion system for the production of chimaera spider silk proteins
Spidroins are well-known for their exceptional mechanical properties, which have inspired extensive research and applications across various fields. Large-scale production of spidroin continues to face major challenges due to the complexity involved in inducing host organisms to express full-length spidroins. This process requires advanced techniques and has issues such as plasmid instability and potential misfolding. In this study, we developed a novel expression system by combining a fusion tag with a self-cleavage intein, enabling the convenient expression of three chimeric spidroins with varying numbers of repetitive units. After optimising expression conditions, NT2RepCT, NT4RepCT and NT6RepCT spidroins were obtained in soluble form, with yields of 266, 135 and 125 mg/L, respectively. All three spidroins exhibited an increased β-sheet content with increased numbers of repetitive units during transition from soluble to dry state. In terms of nanofibril morphologies, the self-assemblies of NT4RepCT and NT6RepCT closely resemble those of native silk proteins. This study can serve as a reference for preparation of high-performance spider silk materials and soluble expression of proteins, such as collagen, and as a foundation for preparation of other structurally complex polymer materials.
- 1 July 2025
- Published by Springer Nature in BMC Biotechnology
- Vol. 25 (1) , 1-10
Open AccessAn engineered self-cleavage fusion system for the production of chimaera spider silk proteins
Spidroins are well-known for their exceptional mechanical properties, which have inspired extensive research and applications across various fields. Large-scale production of spidroin continues to face major challenges due to the complexity involved in inducing host organisms to express full-length spidroins. This process requires advanced techniques and has issues such as plasmid instability and potential misfolding. In this study, we developed a novel expression system by combining a fusion tag with a self-cleavage intein, enabling the convenient expression of three chimeric spidroins with varying numbers of repetitive units. After optimising expression conditions, NT2RepCT, NT4RepCT and NT6RepCT spidroins were obtained in soluble form, with yields of 266, 135 and 125 mg/L, respectively. All three spidroins exhibited an increased β-sheet content with increased numbers of repetitive units during transition from soluble to dry state. In terms of nanofibril morphologies, the self-assemblies of NT4RepCT and NT6RepCT closely resemble those of native silk proteins. This study can serve as a reference for preparation of high-performance spider silk materials and soluble expression of proteins, such as collagen, and as a foundation for preparation of other structurally complex polymer materials.
- 20 June 2025
- Published by Elsevier in Carbohydrate Polymers
- Vol. 366, 123912
Structure-activity relationships study on inhibition of CRISPR-Cas9 by glycosaminoglycans
- 20 June 2025
- Published by Elsevier in Carbohydrate Polymers
- Vol. 366, 123912
Structure-activity relationships study on inhibition of CRISPR-Cas9 by glycosaminoglycans
- Open Access
- 14 May 2025
- Published by Springer Nature in Microbial Cell Factories
- Vol. 24 (1) , 1-13
Scale up of fermentation of recombinant Escherichia coli for efficient production of spider drag silk protein MaSp1s and its dimers
Background: Spider dragline silk exhibits ultrahigh tensile strength and excellent ductility, making it one of the best-performing natural biomaterials. The major ampullate spidroin (MaSp1) has promising applications in the biomedical, chemical, and military industries owing to its good biocompatibility, biodegradability, and low immunogenicity. The generation of recombinant spidroin can significantly facilitate its scaled production but has several challenges, including the high cost of the downstream spidroin solubilization process and the resulting toxicity due to the use of organic solvents. Unlike common MaSp, MaSp short (MaSp1s) from Cyrtophoramoluccensis is a low-molecular-weight spidroin, lacking the typical repetitive sequences and long poly(A) motif. These features enable the heterologous production of soluble spidroin. Results: In this study, rMaSp1 and its dimer rMaSp1s-2Core were expressed in soluble form by introducing the SUMO fusion tag and the self-shearing peptide intein. To improve the yield of recombinant spidroin using shake-flask fermentation, response surface analysis was used to optimize the conditions. The yields of rMaSp1 and rMaSp1s-2Core were 218.9 and 95.76 mg/L, respectively. Subsequently, fermentation was scaled up in a 5 L fermenter after adding metal ions and other growth factors to the medium. The optimal inoculation amount, induction temperature, loaded liquid, and feeding strategy were explored. Finally, the yields of rMaSp1 and rMaSp1s-2Core reached 1,112.2 and 297.8 mg/L, respectively. Furthermore, the dimerization of rMaSp1 monomers was achieved by introducing disulfide bonds via exogenous cysteine residues in the C-terminal domain. The secondary structure and self-assembly of rMaSp1 were also analyzed. Conclusion: This study successfully addressed key challenges in recombinant spidroin production by employing fusion tags (SUMO and self-shearing peptide intein) to enable the soluble expression of rMaSp1 and its dimer rMaSp1s-2Core. The secondary structure and self-assembly analyses further contributed to our understanding of recombinant spidroin. These findings enable the large-scale production of spidroin and its potential applications in the biomedical, chemical, and military industries, overcoming previous hurdles related to the solubility and toxicity associated with downstream processing.
- 14 May 2025
- Published by Springer Nature in Microbial Cell Factories
- Vol. 24 (1) , 1-13
Open AccessScale up of fermentation of recombinant Escherichia coli for efficient production of spider drag silk protein MaSp1s and its dimers
Background: Spider dragline silk exhibits ultrahigh tensile strength and excellent ductility, making it one of the best-performing natural biomaterials. The major ampullate spidroin (MaSp1) has promising applications in the biomedical, chemical, and military industries owing to its good biocompatibility, biodegradability, and low immunogenicity. The generation of recombinant spidroin can significantly facilitate its scaled production but has several challenges, including the high cost of the downstream spidroin solubilization process and the resulting toxicity due to the use of organic solvents. Unlike common MaSp, MaSp short (MaSp1s) from Cyrtophoramoluccensis is a low-molecular-weight spidroin, lacking the typical repetitive sequences and long poly(A) motif. These features enable the heterologous production of soluble spidroin. Results: In this study, rMaSp1 and its dimer rMaSp1s-2Core were expressed in soluble form by introducing the SUMO fusion tag and the self-shearing peptide intein. To improve the yield of recombinant spidroin using shake-flask fermentation, response surface analysis was used to optimize the conditions. The yields of rMaSp1 and rMaSp1s-2Core were 218.9 and 95.76 mg/L, respectively. Subsequently, fermentation was scaled up in a 5 L fermenter after adding metal ions and other growth factors to the medium. The optimal inoculation amount, induction temperature, loaded liquid, and feeding strategy were explored. Finally, the yields of rMaSp1 and rMaSp1s-2Core reached 1,112.2 and 297.8 mg/L, respectively. Furthermore, the dimerization of rMaSp1 monomers was achieved by introducing disulfide bonds via exogenous cysteine residues in the C-terminal domain. The secondary structure and self-assembly of rMaSp1 were also analyzed. Conclusion: This study successfully addressed key challenges in recombinant spidroin production by employing fusion tags (SUMO and self-shearing peptide intein) to enable the soluble expression of rMaSp1 and its dimer rMaSp1s-2Core. The secondary structure and self-assembly analyses further contributed to our understanding of recombinant spidroin. These findings enable the large-scale production of spidroin and its potential applications in the biomedical, chemical, and military industries, overcoming previous hurdles related to the solubility and toxicity associated with downstream processing.
- Open Access
- 24 April 2025
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 13, 1587546
High-yield spidroin mimics for bioinspired fibers via computational design
The exceptional mechanical properties, biocompatibility, and biodegradability of spider silk make it a promising biomaterial, yet large-scale production remains hindered by challenges in heterologous expression. Existing prokaryotic systems face bottlenecks due to spidroins’ high molecular weight, repetitive sequences, and GC-rich motifs, leading to low yields, premature transcription termination, and insoluble inclusion bodies. Addressing these challenges, the study integrates deep learning and bioengineering to design water-soluble, β-sheet-rich spidroin mimics optimized for efficient prokaryotic expression. By replacing polyalanine motifs in Nephila clavipes MaSp1 with computationally screened sequences (e.g., ITVQQ from Burkholderia OspA), five functional spidroins were engineered and solubly expressed in E. coli, achieving yields up to 0.99 g/L. Circular dichroism revealed that modified spidroins (e.g., 3rep-ITVQQ) exhibited β-sheet content up to 81.3% under thermal induction, surpassing unmodified MaSp1 (41.5%). Structural analysis via SEM demonstrated dense, uniform networks in 3rep-ITVQQ, correlating with enhanced mechanical potential. And 24rep-ITVQQ nanofibers were successfully prepared by electrostatic spinning. Coarse-grained molecular dynamics simulations validated progressive self-assembly with reduced solvent-accessible surface area over 1,000 ns. This work bridges the gap between sequence design and scalable production by overcoming expression barriers, simplifying purification, and leveraging β-sheet stacking for tunable mechanical properties. The results provide a blueprint for high-performance biomimetic fibers, advancing applications (e.g., surgical sutures, scaffolds) in tissue engineering and functional materials while addressing the limitations of conventional spidroin production systems.
- 24 April 2025
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 13, 1587546
Open AccessHigh-yield spidroin mimics for bioinspired fibers via computational design
The exceptional mechanical properties, biocompatibility, and biodegradability of spider silk make it a promising biomaterial, yet large-scale production remains hindered by challenges in heterologous expression. Existing prokaryotic systems face bottlenecks due to spidroins’ high molecular weight, repetitive sequences, and GC-rich motifs, leading to low yields, premature transcription termination, and insoluble inclusion bodies. Addressing these challenges, the study integrates deep learning and bioengineering to design water-soluble, β-sheet-rich spidroin mimics optimized for efficient prokaryotic expression. By replacing polyalanine motifs in Nephila clavipes MaSp1 with computationally screened sequences (e.g., ITVQQ from Burkholderia OspA), five functional spidroins were engineered and solubly expressed in E. coli, achieving yields up to 0.99 g/L. Circular dichroism revealed that modified spidroins (e.g., 3rep-ITVQQ) exhibited β-sheet content up to 81.3% under thermal induction, surpassing unmodified MaSp1 (41.5%). Structural analysis via SEM demonstrated dense, uniform networks in 3rep-ITVQQ, correlating with enhanced mechanical potential. And 24rep-ITVQQ nanofibers were successfully prepared by electrostatic spinning. Coarse-grained molecular dynamics simulations validated progressive self-assembly with reduced solvent-accessible surface area over 1,000 ns. This work bridges the gap between sequence design and scalable production by overcoming expression barriers, simplifying purification, and leveraging β-sheet stacking for tunable mechanical properties. The results provide a blueprint for high-performance biomimetic fibers, advancing applications (e.g., surgical sutures, scaffolds) in tissue engineering and functional materials while addressing the limitations of conventional spidroin production systems.